Earth Science Tech Reports 341% Net Income Surge in Q3 2026

Earth Science Tech (OTC: ETST), a strategic holding company operating through subsidiaries in pharmaceuticals, telemedicine, and real estate, reported robust third-quarter fiscal 2026 results ending December 31, 2025. The company achieved revenue of $8.4 million, marking a 14.1% year-over-year increase, with gross profit reaching $6.4 million at an impressive 76.3% margin. Net income soared by 341% to $910,000 compared to the prior-year period, while adjusted EBITDA totaled $1.2 million. Financially, Earth Science Tech strengthened its position with total assets growing to $8.1 million, ending the quarter with $416,000 in cash, $773,000 in working capital, and no bank debt. Management highlighted continued operating leverage and expansion initiatives as key drivers heading into calendar 2026, supported by strategic share repurchases that retired 3.7 million shares during the first nine months of the fiscal year.

The company's diverse operations include compounding pharmaceuticals through RxCompoundStore.com, LLC, telemedicine services via Peaks Curative, LLC, Avenvi, LLC, and DOConsultations, LLC, real estate development through Earth Science Foundation, Inc. and Las Villas Health Care, Inc., and an 80% interest in MagneChef. This multi-faceted approach positions Earth Science Tech across growing healthcare and development sectors. The news release was distributed through BioMedWire (“BMW”), a specialized communications platform within the Dynamic Brand Portfolio @ IBN that focuses on biotechnology, biomedical sciences, and life sciences sectors, providing enhanced press release distribution and corporate communications solutions to reach investors and the public effectively.

For investors seeking detailed information, the full press release is available through the provided link, and ongoing updates about ETST can be found in the company's dedicated newsroom. The strong financial performance, particularly the substantial net income growth and healthy margins, suggests Earth Science Tech is successfully executing its strategy of acquiring and optimizing businesses across complementary sectors. The company's debt-free status and solid working capital provide financial flexibility for continued expansion as it moves into 2026, making this quarterly report significant for stakeholders monitoring the company's progress in the competitive healthcare and real estate development markets.